$VAR1 = undef;
Summary for peptidase C14.010: caspase-9
| Names | |
|---|---|
| MEROPS Name | caspase-9 |
| Other names | CASP9 g.p. (Homo sapiens), ICE-LAP6, Mch6 |
| Domain architecture |
|---|
| MEROPS Classification | |
|---|---|
| Classification | Clan CD >> Subclan (none) >> Family C14 >> Subfamily A >> C14.010 |
| Holotype | caspase-9 (Homo sapiens), Uniprot accession P55211 (peptidase unit: 117-416), MERNUM MER0002707 |
| History | Identifier created: MEROPS 3.02 (25 June 1998) |
| Activity | |||
|---|---|---|---|
| Catalytic type | Cysteine | ||
| Peplist | Included in the Peplist with identifier PL00104 | ||
| NC-IUBMB | Subclass 3.4 (Peptidases) >> Sub-subclass 3.4.22 (Cysteine endopeptidases) >> Peptidase 3.4.22.62 | ||
| Enzymology | BRENDA database | ||
| Proteolytic events | CutDB database (9 cleavages) | ||
| Activity status | human: active (Garcia-Calvo et al., 1999) mouse: active (Fujita et al., 2001) | ||
| Physiology | One of the "initator" caspases in mammalian cell apoptosis, activating caspase-3. | ||
| Knockout | The majority of caspase-9 knockout mice die perinatally with a markedly enlarged and malformed cerebrum caused by reduced apoptosis during brain development (Kuida et al., 1998). | ||
| Pharmaceutical relevance | Inoue et al. (2003) suggest that caspase-9 plays a crucial role in the disease progression of amyotrophic lateral sclerosis, and constitutes a promising therapeutic target. | ||
| Pathways | KEGG | Alzheimer's disease | |
| KEGG | Amyotrophic lateral sclerosis (ALS) | ||
| KEGG | Apoptosis | ||
| KEGG | Colorectal cancer | ||
| KEGG | Hepatitis B | ||
| KEGG | Huntington's disease | ||
| KEGG | Influenza A | ||
| KEGG | Legionellosis | ||
| KEGG | p53 signaling pathway | ||
| KEGG | Parkinson's disease | ||
| KEGG | Pathways in cancer | ||
| KEGG | Small cell lung cancer | ||
| KEGG | Toxoplasmosis | ||
| KEGG | Tuberculosis | ||
| KEGG | Viral myocarditis | ||
| Other databases | WIKIPEDIA | http://en.wikipedia.org/wiki/Caspase-9 | |
| Cleavage site specificity | Explanations of how to interpret the following cleavage site sequence logo and specificity matrix can be found here. | ||
| Cleavage pattern | -/ed/-/D -/-/-/- (based on 14 cleavages) | ||
![]() |
| Specificity matrix | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Human genetics | ||||||
|---|---|---|---|---|---|---|
| Gene symbol | Locus | Megabases | Ensembl | Entrez gene | Gene Cards | OMIM |
| CASP9 | 1p36.1-p36.3 | ENSG00000132906 | 842 | CASP9 | 602234 | |
| Mouse genetics | ||||||
| Gene symbol | Position | Megabases | Ensembl | Entrez gene | MGI | |
| Casp9 | 4:E1 | ENSMUSG00000028914 | 12371 | MGI:1277950 | ||


